Back to Trades
Other4
Denali Therapeutics Inc.
DNLI
Total Value
$60.7K
Company Information
- Company Name
- Denali Therapeutics Inc.
- Ticker Symbol
- DNLI
- CIK
- 0001714899
Insider Information
- Name
- Ho Carole
- Role
- Chief Medical Officer
- Location
- SOUTH SAN FRANCISCO, CA
Officer
Filing Details
- Filing Date
- Aug 7, 2025
- Transaction Date
- Aug 5, 2025
- Accession Number
- 0001714899-25-000153
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Aug 5, 2025 | Common Stock | 44,655 | $0.68 | Exercise | $30.4K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Aug 5, 2025 | Derivative | 44,655 | $0.68 | Exercise | $30.4K |
Footnotes
- (F1)Includes 134,030 Unvested RSUs.
- (F2)The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.
- (F3)The shares are held of record by The Rohatgi-Ho Irrevocable GST Trust for the benefit of the Reporting Person's children.
- (F4)The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the shares subject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days.